Oral Answers to Questions

Debate between Lord Harrington of Watford and Trudy Harrison

Tuesday 16th October 2018 Commons Chamber

[The Parliamentary Under-Secretary of State for Business, Energy and Industrial Strategy (Richard Harrington)]

I thank my hon. Friends for asking this question during Green GB Week. Nuclear power is the key to the UK leading the world in decarbonising its economy, which is why the Government are working hard to secure a good deal at Wylfa, Anglesey and to develop alternative financing models to benefit future projects and implement the landmark nuclear sector deal.

[Trudy Harrison]

Will the Minister recognise the contribution that Cumbria has made to the nuclear industry and commit to working with me and the Moorside strategic partnership to ensure we deliver new nuclear in Copeland?

[Richard Harrington]

One of my most exciting days since I took up this post was spent visiting my hon. Friend’s constituency, and of course I would be delighted to work with her and anyone else in Copeland to develop the Moorside strategic partnership.

Nuclear Safeguards Bill (Second sitting)

Debate between Lord Harrington of Watford and Trudy Harrison

Committee Debate: 2nd sitting: House of Commons
Tuesday 31st October 2017 Public Bill Committees

[Trudy Harrison]

Q Just changing tone slightly, I notice, Kevin, that you have a reference to concern around radioactive isotopes. I do not share that concern. I do not understand why you think this is relevant to Euratom, because they are not fissile material. I have not heard of anyone using plutonium or uranium in medical practice. I wonder, if they have not been risk-assessed by the IAEA, why you would feel there is a concern about their falling under the realms of Euratom.

Kevin Coyne: I think that is an area which is of serious consequence. I think it is generally not well known—the fact that Euratom covers the transportation of materials—or that isotopes that are used in the NHS, for instance, come from Holland and other countries. We do not have the reactors in this country to produce them. I understand what you say about the registration. We highlighted that as a concern because there is a two-day, three-day shelf-life; this comes from us as a union that operates within the NHS at quite an extensive level. In terms of the delivery and transportation of that, there are sometimes delays. So our point is that the change of regimes and the difference in what might occur may cause that to be delayed even further and therefore impact upon the NHS itself. We make no stronger point than that we ought to look at the impact upon isotopes in hospitals.

[Richard Harrington]

Q On that point, if I may clarify, given that that has been brought to my attention—I have agreed to see the Royal College and other people who are interested. Is your point that the movement of the isotopes is perhaps to do with what happens with Brexit—that is, the movement of any foreign goods—or is it a Euratom point? We think on the former you have a point, but on the latter you are mistaken.

Kevin Coyne: A Euratom point—and you think I am mistaken about that?

--- Later in debate ---

[The Chair]

They already are. That has answered the point; good.

[Trudy Harrison]

Q May I ask for clarification? You say they already are: will there be some kind of appraisal of the staff skills, knowledge and qualifications required to carry out the function of Euratom in the UK, to determine what skills are required?

[Richard Harrington]

Is it acceptable for me to answer?